EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study
Go back to EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study| (NASDAQ: EYEG) | Delayed: 33.80 +0.21 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.59 | 52 Week High | $5.09 | |||
| Open | $33.80 | 52 Week Low | $1.11 | |||
| Day High | $33.80 | P/E | N/A | |||
| Day Low | $33.80 | EPS | $0.00 | |||
| Volume | 132 | |||||



